Medical Marijuana Segmentation
The medical marijuana market is segmented by end- user, by product, by application, and by region. On the basis of end user, the market is segmented into hospitals, clinics and others, and the segment for hospitals is anticipated to hold the leading market share as these institutions use the medicine to treat chronic diseases and for therapies as well. Moreover, the drug can only be used if there is a prescription in several regions.
Our in-depth analysis of the global market includes the following segments:
|
By End- user |
|
|
By Product |
|
|
Application |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of medical marijuana is evaluated at USD 22.99 billion.
Medical Marijuana Market size was valued at USD 19.42 billion in 2024 and is set to exceed USD 246.82 billion by 2037, expanding at over 21.6% CAGR during the forecast period i.e., between 2025-2037.
North America industry is likely to dominate majority revenue share by 2037, as a result of legalization of the drug in several parts of the region and increased knowledge of the medicinal properties of the drug.
The major players in the market are Aphria Inc., Canopy Growth Corp., Tilray, GW Pharmaceuticals plc, Aurora Cannabis, Maricann Group Inc., Lexaria Corp., Tikun Olam Ltd., United Cannabis Corp., and others.
